Company Overview
REV-MED is a biomedical company specializing in advanced technologies for autologous cell-based therapies and regenerative medicine.
With proprietary expertise in the separation, concentration, and extraction of biological components derived from the human body, REV-MED develops innovative solutions designed to preserve the integrity of blood- and bone marrow-derived components while maximizing the utilization of viable cells and growth factors.
Our differentiated technologies have been applied across a wide range of medical fields, including orthopedics and dermatology, demonstrating both strong technological capabilities and broad clinical potential.
REV-MED’s technology goes beyond conventional separation and processing. By enabling the precise, stable, and efficient utilization of autologous biological components, our platform provides a foundation for expanding applications in tissue regeneration, pain management, and regenerative medicine.
Driven by our mission to help restore healthier lives through innovative biomedical technologies, REV-MED continues to advance its core technologies and expand its presence in global markets.
Through this exhibition, we look forward to presenting our key products and technologies, connecting with global partners, and exploring new opportunities for collaboration in the future of regenerative medicine.
Its flagship product, NovaStem BC, is a blood separation and extraction medical device designed to isolate and concentrate key components from a patient’s own blood, including platelets, immune cells, and stem cells. Featuring REV-MED’s proprietary three-chamber separation mechanism, NovaStem BC is engineered to minimize the loss of valuable biological components during processing.
Building on these differentiated technological capabilities, REV-MED is expanding beyond tissue regeneration into broader areas of regenerative medicine while actively pursuing opportunities in global markets.
With proprietary expertise in the separation, concentration, and extraction of biological components derived from the human body, REV-MED develops innovative solutions designed to preserve the integrity of blood- and bone marrow-derived components while maximizing the utilization of viable cells and growth factors.
Our differentiated technologies have been applied across a wide range of medical fields, including orthopedics and dermatology, demonstrating both strong technological capabilities and broad clinical potential.
REV-MED’s technology goes beyond conventional separation and processing. By enabling the precise, stable, and efficient utilization of autologous biological components, our platform provides a foundation for expanding applications in tissue regeneration, pain management, and regenerative medicine.
Driven by our mission to help restore healthier lives through innovative biomedical technologies, REV-MED continues to advance its core technologies and expand its presence in global markets.
Through this exhibition, we look forward to presenting our key products and technologies, connecting with global partners, and exploring new opportunities for collaboration in the future of regenerative medicine.
Its flagship product, NovaStem BC, is a blood separation and extraction medical device designed to isolate and concentrate key components from a patient’s own blood, including platelets, immune cells, and stem cells. Featuring REV-MED’s proprietary three-chamber separation mechanism, NovaStem BC is engineered to minimize the loss of valuable biological components during processing.
Building on these differentiated technological capabilities, REV-MED is expanding beyond tissue regeneration into broader areas of regenerative medicine while actively pursuing opportunities in global markets.
